A continuous glucose monitor (CGM) is a small sensor worn on the skin, typically the back of the upper arm, that measures glucose levels every few minutes around the clock, transmitting readings to a smartphone app. Originally developed for diabetes management, CGMs have increasingly moved into general metabolic health use, revealing real-time glucose patterns, specific meal responses, and overnight trends that a single fasting blood draw, capturing just one moment in time, was never designed to show, giving both diabetics and non-diabetics a different kind of information than any single lab test can provide.
- Readings come every 1-5 minutes, continuously, versus a single point-in-time fasting blood draw.
- "Time in Range," the percentage of the day spent within a target glucose window, is the key metric CGM data is built around.
- For non-diabetics optimizing metabolic health, over 90% Time in Range (roughly 70-140 mg/dL) is a strong target.
- Sensors measure interstitial fluid, not blood directly, introducing a short, predictable time lag versus a blood glucose reading.
How a CGM works
A CGM sensor sits just under the skin's surface, using a small, thin filament to measure glucose concentration in the interstitial fluid, the fluid surrounding your cells, rather than sampling blood directly the way a fingerstick or blood draw does. An enzyme on the sensor reacts with glucose in this fluid, producing a small electrical signal proportional to glucose concentration, which the sensor's electronics convert into a glucose reading transmitted wirelessly to a receiver or smartphone app, typically every 1-5 minutes depending on the specific device. The sensor itself is applied with a simple, largely painless applicator, and once in place, requires no further action from the wearer beyond occasionally scanning or syncing with the paired app, depending on the specific technology.
Because interstitial fluid glucose lags slightly behind blood glucose, roughly 5-15 minutes depending on how quickly your glucose is changing, CGM readings aren't perfectly synchronized with what a blood draw would show at the exact same moment, particularly during rapid glucose swings right after a meal. This lag is well understood and consistent enough that it doesn't meaningfully undermine the technology's usefulness for spotting patterns and trends, which is what CGM data is primarily used for, rather than needing split-second precision for any single reading. Modern devices also apply their own internal algorithms to smooth and correct raw sensor signal, further reducing the practical impact of this lag on the data a user actually sees.
Most consumer and clinical CGM sensors are worn continuously for 10-14 days before needing replacement, providing a genuinely continuous data stream across that entire window, including overnight sleep, a period essentially invisible to any single-point testing method, since almost nobody is waking up specifically to get a blood draw at 3am. This continuous coverage is arguably the single biggest structural advantage CGM data has over any snapshot-based testing method, regardless of how accurate that snapshot method might be at the single moment it's taken.
What CGM data has not been shown to predict
Time in Range is a well-standardised metric for managing diabetes, with consensus targets and a large literature behind it.
Its value as a longevity marker in people without diabetes is a different question. That value is inferred from the glucose literature generally rather than demonstrated by outcome research on CGM-derived metrics themselves. There is limited long-term research linking those metrics to hard health outcomes in non-diabetics, in contrast to the decades of such research behind HbA1c and fasting glucose.
What a CGM reveals that a fasting test can’t
The most immediately useful CGM insight for most people is individual meal response: how much a specific food raises your glucose, and how quickly it returns to baseline.
That varies meaningfully between individuals even for identical meals. Differences in gut microbiome composition, insulin sensitivity, sleep the night before, stress levels, and the order and combination of foods eaten all contribute.
A fasting test cannot provide any of it. It captures a single overnight-fasted state, with no visibility into how a body actually processes food through the rest of the day.
CGM data also reveals overnight glucose patterns, showing whether glucose stays stable through the night or rises unexpectedly. Those rises are sometimes linked to poor sleep quality, late meals, or the dawn phenomenon, a natural morning glucose rise driven by cortisol and other hormones.
It also shows how glucose responds to exercise, both during a workout and in the hours afterward. Insulin sensitivity is often temporarily elevated then, sometimes producing a noticeably flatter response to a meal eaten shortly after training than to the same meal at rest.
A CGM can also reveal individual sensitivity to specific food categories that population-level nutrition advice cannot predict for any one person. Two people can eat the same bowl of rice and see meaningfully different glucose responses.
That information is invisible without continuous individual measurement, and a single fasting test was never designed to capture it.
CGM vs. fasting glucose vs. HbA1c
These three methods aren't competing alternatives so much as complementary tools answering different questions, fasting glucose gives a quick snapshot, HbA1c gives a long-run average, and CGM gives the continuous, moment-to-moment detail neither of the other two was ever designed to capture.
| CGM | Fasting Glucose | HbA1c | |
|---|---|---|---|
| What it captures | Continuous, real-time | A single moment | ~2-3 month average |
| Reveals meal-specific spikes | Yes | No | No |
| Requires fasting | No | Yes | No |
| Typical use duration | 10-14 days per sensor | Single blood draw | Single blood draw |
| Best for | Identifying specific triggers | Quick screening | Long-term trend, diagnosis |
The target above 70 percent within 70 to 180 mg/dL is the international consensus recommendation for people with diabetes (Battelino et al., 2019). The above-90-percent within 70 to 140 mg/dL target for people without diabetes is Longevity Coach IQ’s own, extrapolated from the glucose literature rather than set by a clinical body.
Fasting glucose is covered here because it is the single-point measurement CGM data is usually compared against, and because insulin resistance develops years before fasting glucose rises. That makes fasting glucose a late signal, which is precisely what continuous data is meant to get ahead of.
Fasting glucose interpreter
Range-optimal rather than lower-is-better: the top band has a floor at 72 mg/dL.
Time in Range targets
"Time in Range" (TIR), the percentage of readings falling within a target glucose window, is the primary metric CGM data is organized around, Longevity Coach IQ's own target, not a consensus recommendation developed by a panel of diabetes technology researchers and clinicians specifically to standardize how CGM data gets reported and interpreted:
| Population | Target range | TIR goal |
|---|---|---|
| General metabolic health (no diabetes) | 70 – 140 mg/dL | Above 90% |
| Type 1 or Type 2 diabetes (standard clinical target) | 70 – 180 mg/dL | Above 70% |
Comparison of what each method captures and what each is best suited to.
Time spent above or below the target range also matters, not just the overall percentage, spending even a small fraction of time in significant hyperglycemia (very high) or hypoglycemia (very low) carries its own separate consideration, distinct from the overall Time in Range number alone. Most consensus guidance recommends keeping time below range to a small fraction of the day even when overall TIR looks strong, since low glucose events carry their own distinct risks separate from simply optimizing the headline percentage, and are worth monitoring in their own right rather than folding entirely into a single combined score.
How to interpret CGM data
Rather than fixating on any single reading, useful CGM interpretation focuses on patterns across multiple days: which meals consistently produce the largest spikes, how quickly glucose returns to baseline after eating, whether overnight glucose stays stable, and how specific interventions (a walk after eating, eating protein before carbs, more sleep) measurably change the pattern. A single unusually high reading is far less informative than a repeated pattern across several similar meals or days, and drawing strong conclusions from one isolated data point is one of the more common ways people misuse CGM data in practice.
Most CGM apps provide visual graphs making these patterns easy to spot at a glance, and many people find the immediate, visual feedback loop, seeing exactly how a specific food affected their glucose within the hour, more motivating and actionable than an abstract lab value received days after a blood draw. This immediacy is part of what's driven CGM adoption well beyond the diabetes population it was originally built for, the feedback loop itself changes behavior for some people in a way a delayed lab result simply doesn't.
The shape of a glucose curve is worth tracking, not just its peak. A sharp spike followed by a rapid return to baseline behaves differently from a smaller rise that stays elevated for hours.
The second pattern generally indicates more difficulty clearing glucose, which is the more meaningful signal of the two.
CGM accuracy and limitations
CGM accuracy has improved substantially in recent generations of devices, but sensors can still occasionally produce inaccurate readings, particularly in the first day after a new sensor is applied, during rapid glucose changes, or due to sensor compression during sleep (lying on the sensor arm). Most devices include some degree of built-in calibration or correction to manage this, but isolated unusual readings shouldn't be over-interpreted without corroborating pattern data, a single strange spike in the middle of the night is more likely a sensor artifact than a genuine metabolic event, especially if it doesn't repeat.
For non-diabetics specifically, long-term outcome research linking CGM-derived metrics to hard health outcomes is limited.
That contrasts with the decades of such research behind HbA1c and fasting glucose, and CGM use for general metabolic health optimization is a much newer application than the technology was originally validated for.
Certain substances can interfere with specific sensor models, including high-dose vitamin C and some medications.
Sensor accuracy also varies between manufacturers and between individual sensors, and readings are typically least reliable in the first 12 to 24 hours after application.
Common misconceptions
"Any glucose spike is bad and should be avoided entirely." Some glucose rise after eating is completely normal and expected. The relevant question is the size and duration of the spike, and how quickly it returns to baseline, not whether any rise happens at all. Treating every spike as an alarming failure tends to produce more anxiety than useful behavior change.
"CGM readings are exactly as accurate as a blood draw at every moment." They are very useful for spotting patterns and trends. The interstitial fluid measurement and slight time lag mean individual readings can differ from a simultaneous blood draw, especially during rapid glucose changes. That difference matters far less for pattern recognition than it would for a single critical clinical decision.
"I need a CGM to know if I have prediabetes or diabetes." Standard fasting glucose and HbA1c testing remain the established diagnostic tools for these conditions, a CGM is more useful for ongoing pattern monitoring and behavior optimization than as a primary diagnostic tool, and shouldn't be relied on as a substitute for standard diagnostic bloodwork.
"Wearing a CGM automatically improves your metabolic health." The device itself changes nothing. It is a data source, and the benefit comes entirely from what someone does in response to the patterns it reveals. Wearing one passively without acting on the information provides little beyond curiosity.
Getting something useful out of a sensor
Wellness media treats a CGM as a trendy gadget rather than a diagnostic tool. Glucose patterns sit where metabolic dysfunction and excess visceral fat meet, which is what makes the data useful feedback rather than a curiosity.
Wear a sensor for one 10 to 14 day cycle to find your own meal and lifestyle triggers, then act on what it shows. Wearing one continuously without changing anything is the common failure.
Focus on Time in Range and the shape of your curves rather than individual spikes. A single high reading after one meal tells you much less than the pattern across a fortnight.
It tracks your glucose patterns alongside your body composition and metabolic scores, showing whether your highest-priority efforts are actually working.
Sources
Key references for the claims on this page. Where a figure is attributed to a specific study or body, it is named here.
- Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care, 2019;42(8):1593–1603. The consensus targets for people with diabetes quoted above. DOI
The interstitial lag and sensor accuracy points on this page are stated qualitatively rather than against a specific published figure.
Frequently asked
What is the best fasting glucose for longevity?
Below 100 mg/dL is the standard normal range, and the optimized bands sit in the low 80s to low 90s. Fasting glucose is a late signal, since insulin resistance develops years before it rises, so pairing it with fasting insulin or HbA1c gives a considerably earlier picture.
What is a continuous glucose monitor?
A small sensor worn on the skin that measures glucose every few minutes continuously, revealing patterns a single fasting blood draw can't show.
What is a good Time in Range?
For non-diabetics, over 90% of time within roughly 70-140 mg/dL is a strong target, Longevity Coach IQ's own target, not a consensus recommendation.
Do I need diabetes to benefit from a CGM?
No, CGMs are increasingly used by people without diabetes to understand individual glucose response to food, exercise, sleep, and stress.
How long does a CGM sensor last?
Typically 10-14 days per sensor, depending on the specific device, after which it's replaced with a new one.
Can I exercise or swim while wearing a CGM?
Yes, most modern sensors are water-resistant and designed to stay in place through normal exercise and swimming, though checking the specific device's guidance is worth doing before intense activity.
Does a CGM require a doctor's prescription?
Requirements vary, some CGMs are available over the counter for general wellness use, while others, particularly those intended for diabetes management, require a prescription depending on the country and specific product.